Rapid Cytoreduction in Acute Leukemia
- 2 January 1978
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 18 (1) , 113-115
- https://doi.org/10.1046/j.1537-2995.1978.18178118553.x
Abstract
A patient with acute myelogenous leukemia and symptoms of cerebral leukostasis failed to respond to initial chemotherapy. Reduction in blast count from 200,000/.mu.l to 40,000/.mu.l was accomplished over a 5-h period by leukapheresis using an intermittent flow cell separator, and symptomatic improvement was dramatic. The technique is simple and rapidly effective and may prove a useful adjunct in the treatment of patients with acute leukemia and high blast counts.This publication has 13 references indexed in Scilit:
- Management of Chronic Myelocytic Leukemia in Pregnancy by Cell PheresisTransfusion, 1978
- Successful Control of Life‐Threatening Thrombocytosis with a Blood ProcessorTransfusion, 1975
- Successful Management of the Sézary SyndromeNew England Journal of Medicine, 1974
- Hyperphosphatemia, Hyperphosphaturia and Hypocalcemia in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1973
- Biological Effects of Repeated Leukapheresis of Patients With Chronic Myelogenous LeukemiaBlood, 1973
- Fatal Pulmonary Leukostasis Following Treatment in Acute Myelogenous LeukemiaArchives of internal medicine (1960), 1972
- Hyperuricemia complicating leukemia: treatment with allopurinol and dialysisArchives of internal medicine (1960), 1969
- Significance of blood lactate elevations among patients with acute leukemia and other neoplastic proliferative disordersThe American Journal of Medicine, 1966
- Clinical trials of hydroxyurea in patients with cancer and leukemiaClinical Pharmacology & Therapeutics, 1964
- The Association of Fatal Intracranial Hemorrhage and Blastic Crisis in Patients with Acute LeukemiaNew England Journal of Medicine, 1959